Emendo Biotherapeutics signs licensing agreement with Takeda Pharmaceutical for OMNI nuclear program April 25, 2019
Forge Therapeutics, Basilea Pharmaceutica enter research collaboration to develop novel antibiotics April 25, 2019
PureTech and Boehringer to develop immune-oncology candidates using lymphatic targeting platform April 18, 2019
SK Biopharmaceuticals and twoXAR collaborate to discover and develop first-in-class drugs for NSCLC April 18, 2019
Gilead and insitro enter strategic collaboration to discover and develop new therapies for NASH April 17, 2019
RSS